Survival, non-relapse mortality, and relapse-related mortality after allogeneic hematopoietic cell transplantation: Comparing 2003-2007 vs. 2013-2017 cohorts

BACKGROUND: Allogeneic hematopoietic cell transplantation is indicated for refractory hematologic malignancy and some non-malignant disorders. Survival is limited by recurrent malignancy and organ toxicity. OBJECTIVE: We determined whether survival has improved over the last decade and noted impedim...

Full description

Saved in:
Bibliographic Details
Published in:Ann Intern Med
Main Authors: McDonald, George B., Sandmaier, Brenda M., Mielcarek, Marco, Sorror, Mohamed, Pergam, Steven A., Cheng, Guang-Shing, Hingorani, Sangeeta, Boeckh, Michael, Flowers, Mary D., Lee, Stephanie J., Appelbaum, Frederick R., Storb, Rainer, Martin, Paul J., Deeg, H. Joachim, Schoch, Gary, Gooley, Ted A.
Format: Artigo
Language:Inglês
Published: 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7847247/
https://ncbi.nlm.nih.gov/pubmed/31958813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/M19-2936
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items